trivago N.V.: Dr. Joana Carena Breidenbach, Acquisition

trivago disclosed an employee-program-linked derivative acquisition by board member Dr. Joana Carena Breidenbach with a reported volume of 10,500 EUR.

Rhea-AI Summary

trivago (TRVG) reported an acquisition of derivatives by supervisory board member Dr. Joana Carena Breidenbach on 10 August 2026.

The transaction involves a derivative instrument with ISIN US89686D3035, executed on Nasdaq (MIC: XNAS). The nature of the transaction is classified as an acquisition linked to an employee share participation programme, and it is an initial notification under manager transaction rules.

The reported price is 0.30 EUR per instrument, with an aggregated transaction volume of 10,500 EUR. The issuer is identified as trivago N.V. with LEI 391200MJ56OU7D3JM080, and the notification is made as a regulatory disclosure of dealings by a person discharging managerial responsibilities.

News Explained

The derivative’s ownership effect is unspecified, while separate records show the director’s recent activity was net selling.

The trivago disclosure records Dr. Joana Carena Breidenbach’s August 10, 2026 acquisition of a derivative under an employee share participation programme; it gives no conversion terms or common-share outcome, so a change in existing ownership is not established.

The supplied 90-day insider record shows two sales by Breidenbach totaling 37,733 shares and no purchases, making the broader recorded activity net selling.

Market Context

TRVG's recent insider record was marked Net Selling, adding a platform-level caution alongside this ...

Analysis

TRVG's recent insider record was marked Net Selling, adding a platform-level caution alongside this option-linked acquisition notice. The relevant watchpoint is whether subsequent disclosures clarify the transaction's economic significance; low short positioning was also recorded.

Key Figures

Transaction Price: 0.30 EUR Transaction Volume: 10,500 EUR Transaction Date: 10.08.2026

3 metrics

Transaction Price 0.30 EUR Option-linked acquisition

Transaction Volume 10,500 EUR Option-linked acquisition

Transaction Date 10.08.2026 Acquisition notification

Historical Context

5 past events · Latest: Aug 04 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 04	Earnings report	Positive	-2.5%	Revenue growth and raised guidance were followed by a 2.45% decline.
Jul 27	Earnings scheduling	Neutral	-1.1%	Second-quarter results scheduling was followed by a 1.1% decline.
Jun 29	Trading restoration	Positive	+4.6%	ADR trading resumed on German exchanges, followed by a 4.59% gain.
May 05	Earnings report	Positive	+10.8%	First-quarter growth and improved guidance coincided with a 10.76% gain.
May 05	Antitrust claim	Positive	+10.8%	The antitrust damages claim was followed by a 10.76% gain.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The historical record was mixed: two positive announcements aligned with gains, while the August earnings release diverged with a decline.

Key Terms

derivative, isin, lei, persons discharging managerial responsibilities

4 terms

derivative financial

"Description of the financial instrument — Type | Derivative"

A derivative is a financial contract whose value depends on the price or performance of another asset or measure — for example a stock, index, interest rate, commodity, or currency. Investors use derivatives like insurance or leveraged bets to hedge risk, speculate, or gain exposure without owning the underlying asset; they can protect portfolios but also amplify losses and introduce counterparty and market risk.

isin financial

"Description of the financial instrument — ISIN | US89686D3035"

A 12-character International Securities Identification Number (ISIN) is a unique code that acts like a passport for a specific stock, bond or other tradable security so it can be identified worldwide. Investors and systems use it to ensure they are buying, selling and tracking the exact same instrument across exchanges and data feeds, which prevents costly mix-ups and makes portfolio reporting, settlement and regulatory checks simpler and more reliable.

View in glossary

lei regulatory

"Details of the issuer — LEI | 391200MJ56OU7D3JM080"

A Legal Entity Identifier (LEI) is a unique 20-character code assigned to a company or organization that participates in financial markets, like a corporate passport number. It helps investors and regulators unambiguously identify counterparties across databases and transactions, reducing confusion much like using a vehicle identification number to track a car’s history; clearer identification improves transparency, risk monitoring, and regulatory reporting.

View in glossary

persons discharging managerial responsibilities regulatory

"public disclosure of transactions by persons discharging managerial responsibilities"

Persons Discharging Managerial Responsibilities are the key people in a company who make big decisions, like top managers or executives. Knowing who they are is important because their actions can influence the company’s success or failure, and they are often required to share information about their dealings to ensure transparency for investors and the public.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

trivago N.V.: Dr. Joana Carena Breidenbach, Acquisition

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them,
04. Sep 2026 / 22:00 CET/CEST, transmitted by GlobeNewswire.

The issuer is solely responsible for the content of this announcement.

---

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title	Dr.
First name	Joana Carena
Last name	Breidenbach

2. Reason for the notification

a) Position / status

Member of the administrative or supervisory body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

trivago N.V.

b) LEI

391200MJ56OU7D3JM080

4. Details of the transaction(s)

a) Description of the financial instrument

Type	Derivative
ISIN	US89686D3035

b) Nature of the transaction

Acquisition

Transaction linked to the exercise of a share option programme

Transaction under an employee share participation programme

c) Price(s) and volume(s)

Price(s)	Volume(s)
0.30 EUR	10,500 EUR

d) Aggregated information

Price	Aggregated volume
0.30 EUR	10,500 EUR

e) Date of the transaction (CET/CEST)

10.08.2026

f) Place of the transaction

Name	Nasdaq
MIC	XNAS

End of message

---

GlobeNewsWire Distribution Services include regulatory announcements, financial/corporate news and press releases.

Archive at www.globenewswire.com

---

Language	English
Company	trivago N.V.
	Kesselstraße 5 – 7
	40221 Düsseldorf
	Germany
Internet	https://www.trivago.com/

FAQ

What insider transaction involving TRVG did Dr. Joana Carena Breidenbach report?

Dr. Joana Carena Breidenbach, a member of trivago’s administrative or supervisory body, reported an acquisition of a derivative related to trivago (TRVG). The transaction is linked to an employee share participation programme and constitutes an initial notification under manager transaction regulations.

What were the price and volume of Dr. Breidenbach’s TRVG derivative acquisition?

The reported transaction price for the trivago-related derivative was 0.30 EUR, with an aggregated transaction volume of 10,500 EUR. These figures reflect the total value disclosed for the acquisition in the regulatory notification.

When and where was the TRVG insider transaction by Dr. Breidenbach executed?

The transaction by Dr. Joana Carena Breidenbach was executed on 10 August 2026 and took place on Nasdaq, identified by market identifier code XNAS. This timing and venue are specified in the regulatory disclosure of the deal.

What type of financial instrument did Dr. Breidenbach acquire in relation to TRVG?

The financial instrument acquired is classified as a derivative tied to trivago (TRVG), with ISIN US89686D3035. The company states that the transaction is under an employee share participation programme, indicating it is part of a structured employee-related scheme.

How is trivago N.V. identified in the insider transaction disclosure for TRVG?

In the disclosure, the issuer is trivago N.V., identified with the legal entity identifier 391200MJ56OU7D3JM080. This identification confirms the company whose instruments are subject to the reported derivative acquisition by Dr. Joana Carena Breidenbach.